FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | Citation |
| Id | Citation-58.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: Citation 58
version: 32; Last updated: 2025-10-13 16:59:33+0000
ArtifactPublicationStatus: Active
identifier: FEvIR Object Identifier/58, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.15.20
version: 1.0.0-ballot3
title: Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)
status: Active
date: 2022-01-10 13:29:15+0000
author: Brian S. Alper:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.
| Code | Value[x] |
| Citation Classification Type: fevir-platform-use (FEvIR Platform Use) | FHIR Resource |
jurisdiction: World
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
| Style | Text |
| Computable Publishing | 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55. |
citedArtifact
identifier: FEvIR Object Identifier/55
dateAccessed: 2021-03-13
StatusDates
Activity Actual Period Created true ?? --> 2020-12-17 Titles
Type Text Primary title 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY).
Abstracts
Type Text Copyright Primary human use COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis
https://creativecommons.org/licenses/by-nc-sa/4.0/
publicationForm
PublishedIns
Type Title Publisher PublisherLocation Database Fast Evidence Interoperability Resources (FEvIR) Platform Computable Publishing LLC Ipswich, MA, USA lastRevisionDate: 2020-12-21
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
webLocation
classifier: JSON, Computable resource
classification
type: Knowledge Artifact Type
classifier: FHIR Resource
classification
type: fhir-resource
classifier: Evidence
classification
type: defined-in-text
classifier: remdesivir, COVID-19, pharmaceutical treatment
contributorship
complete: true
entry
contributor: Practitioner Brian S. Alper
forenameInitials: BS
affiliation: Computable Publishing LLC
contributionType: Conceptualization, Data curation, Supervision
role: Author/Creator
correspondingContact: true
entry
contributor: Practitioner Joanne Dehnbostel
forenameInitials: J
affiliation: Computable Publishing LLC
contributionType: Formal analysis, Data curation
role: Author/Creator
correspondingContact: false
entry
contributor: Practitioner Khalid Shahin
forenameInitials: K
affiliation: Computable Publishing LLC
contributionType: Software
role: Author/Creator
correspondingContact: false
Generated Narrative: Practitioner #contributor0
identifier:
https://orcid.org//0000-0003-4300-4928name: Brian S. Alper
telecom: balper@computablepublishing.com
Generated Narrative: Practitioner #contributor1
name: Joanne Dehnbostel
telecom: jdehnbostel@computablepublishing.com
Generated Narrative: Practitioner #contributor2
name: Khalid Shahin
telecom: kshahin@computablepublishing.com
{
"resourceType": "Citation",
"id": "58",
"meta": {
"versionId": "32",
"lastUpdated": "2025-10-13T16:59:33.089Z"
},
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"contained": [
{
"resourceType": "Practitioner",
"id": "contributor0",
"identifier": [
{
"system": "https://orcid.org/",
"value": "0000-0003-4300-4928",
"assigner": {
"display": "ORCID"
}
}
],
"name": [
{
"family": "Alper",
"given": [
"Brian S."
]
}
],
"telecom": [
{
"system": "email",
"value": "balper@computablepublishing.com"
}
]
},
{
"resourceType": "Practitioner",
"id": "contributor1",
"name": [
{
"family": "Dehnbostel",
"given": [
"Joanne"
]
}
],
"telecom": [
{
"system": "email",
"value": "jdehnbostel@computablepublishing.com"
}
]
},
{
"resourceType": "Practitioner",
"id": "contributor2",
"name": [
{
"family": "Shahin",
"given": [
"Khalid"
]
}
],
"telecom": [
{
"system": "email",
"value": "kshahin@computablepublishing.com"
}
]
}
],
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "active",
"display": "Active"
}
]
}
}
],
"url": "https://fevir.net/resources/Citation/58",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "58",
"assigner": {
"display": "Computable Publishing LLC"
}
},
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.4.642.40.44.15.20"
}
],
"version": "1.0.0-ballot3",
"title": "Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)",
"status": "active",
"date": "2022-01-10T13:29:15.764Z",
"author": [
{
"name": "Brian S. Alper"
}
],
"publisher": "HL7 International / Clinical Decision Support",
"contact": [
{
"name": "HL7 International / Clinical Decision Support",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/dss"
}
]
}
],
"description": "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"useContext": [
{
"code": {
"system": "http://terminology.hl7.org/CodeSystem/citation-classification-type",
"code": "fevir-platform-use",
"display": "FEvIR Platform Use"
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier",
"code": "fhir-resource",
"display": "FHIR Resource"
}
]
}
}
],
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"summary": [
{
"style": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/citation-summary-style",
"code": "comppub",
"display": "Computable Publishing"
}
]
},
"text": "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55."
}
],
"citedArtifact": {
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net",
"value": "55",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"dateAccessed": "2021-03-13",
"statusDate": [
{
"activity": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "created",
"display": "Created"
}
]
},
"actual": true,
"period": {
"end": "2020-12-17"
}
}
],
"title": [
{
"type": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/title-type",
"code": "primary",
"display": "Primary title"
}
]
}
],
"text": "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)."
}
],
"abstract": [
{
"type": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type",
"code": "primary-human-use",
"display": "Primary human use"
}
]
}
],
"text": "COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis",
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/"
}
],
"publicationForm": [
{
"publishedIn": {
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/published-in-type",
"code": "D019991",
"display": "Database"
}
]
},
"title": "Fast Evidence Interoperability Resources (FEvIR) Platform",
"publisher": {
"type": "Organization",
"display": "Computable Publishing LLC"
},
"publisherLocation": "Ipswich, MA, USA"
},
"lastRevisionDate": "2020-12-21",
"copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/"
}
],
"webLocation": [
{
"classifier": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier",
"code": "json",
"display": "JSON"
}
]
},
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier",
"code": "computable-resource",
"display": "Computable resource"
}
]
}
],
"url": "https://fevir.net/resources/Evidence/55"
}
],
"classification": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type",
"code": "knowledge-artifact-type",
"display": "Knowledge Artifact Type"
}
]
},
"classifier": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier",
"code": "fhir-resource",
"display": "FHIR Resource"
}
]
}
]
},
{
"type": {
"text": "fhir-resource"
},
"classifier": [
{
"coding": [
{
"system": "http://hl7.org/fhir/fhir-types",
"code": "Evidence",
"display": "Evidence"
}
]
}
]
},
{
"type": {
"text": "defined-in-text"
},
"classifier": [
{
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "defined-in-text",
"display": "Defined in text"
}
],
"text": "remdesivir"
},
{
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "defined-in-text",
"display": "Defined in text"
}
],
"text": "COVID-19"
},
{
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "defined-in-text",
"display": "Defined in text"
}
],
"text": "pharmaceutical treatment"
}
]
}
],
"contributorship": {
"complete": true,
"entry": [
{
"contributor": {
"reference": "#contributor0",
"type": "Practitioner"
},
"forenameInitials": "BS",
"affiliation": [
{
"display": "Computable Publishing LLC"
}
],
"contributionType": [
{
"coding": [
{
"system": "http://hl7.org/fhir/artifact-contribution-type",
"code": "conceptualization",
"display": "Conceptualization"
}
]
},
{
"coding": [
{
"system": "http://hl7.org/fhir/artifact-contribution-type",
"code": "data-curation",
"display": "Data curation"
}
]
},
{
"coding": [
{
"system": "http://hl7.org/fhir/artifact-contribution-type",
"code": "supervision",
"display": "Supervision"
}
]
}
],
"role": {
"coding": [
{
"system": "http://hl7.org/fhir/contributor-role",
"code": "author",
"display": "Author/Creator"
}
]
},
"correspondingContact": true
},
{
"contributor": {
"reference": "#contributor1",
"type": "Practitioner"
},
"forenameInitials": "J",
"affiliation": [
{
"display": "Computable Publishing LLC"
}
],
"contributionType": [
{
"coding": [
{
"system": "http://hl7.org/fhir/artifact-contribution-type",
"code": "formal-analysis",
"display": "Formal analysis"
}
]
},
{
"coding": [
{
"system": "http://hl7.org/fhir/artifact-contribution-type",
"code": "data-curation",
"display": "Data curation"
}
]
}
],
"role": {
"coding": [
{
"system": "http://hl7.org/fhir/contributor-role",
"code": "author",
"display": "Author/Creator"
}
]
},
"correspondingContact": false
},
{
"contributor": {
"reference": "#contributor2",
"type": "Practitioner"
},
"forenameInitials": "K",
"affiliation": [
{
"display": "Computable Publishing LLC"
}
],
"contributionType": [
{
"coding": [
{
"system": "http://hl7.org/fhir/artifact-contribution-type",
"code": "software",
"display": "Software"
}
]
}
],
"role": {
"coding": [
{
"system": "http://hl7.org/fhir/contributor-role",
"code": "author",
"display": "Author/Creator"
}
]
},
"correspondingContact": false
}
]
}
}
}